Abstract
The aim of this initiative was to provide consensus recommendations from a consortium of academic and industry experts in the field of lymphoma and imaging for the consistent application of imaging assessment with the Lugano classification. Methods: Consensus was obtained through a series of meetings from July 2019 to October 2021 sponsored by the PINTaD (Pharma Imaging Network for Therapeutics and Diagnostics) as part of the ProLoG (PINTaD RespOnse criteria in Lymphoma wOrking Group) consensus initiative. Results: Consensus recommendations encompass all technical imaging aspects of the Lugano classification. Some technical considerations for PET/CT and diagnostic CT are clarified with regards to required imaging series and scan visits, as well as acquisition and reconstruction of PET images and influence of lesion size and background activity. Recommendations are given on the role of imaging and clinical reviewers as well as on training and monitoring. Finally, an example template of an imaging case report form is provided to support efficient collection of data with Lugano Classification. Conclusion: Consensus recommendations are made to comprehensively address technical and imaging areas of inconsistency and ambiguity in the classification encountered by end users. Such guidance should be used to support standardized acquisition and evaluation with the Lugano 2014.
Keywords:
Lugano classification; consensus; standardization; technical recommendations.
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Consensus
-
Fluorodeoxyglucose F18
-
Humans
-
Lymphoma* / pathology
-
Lymphoma, Non-Hodgkin* / diagnostic imaging
-
Lymphoma, Non-Hodgkin* / pathology
-
Neoplasm Staging
-
Positron Emission Tomography Computed Tomography